Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.37 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MGAM | O43451 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SI | P14410 | 1/20 | 0.36 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1035817 | 0.85 | KDM4E (0.37) | NLRP3CYP3A4SMN1; SMN2MEN1KMT2A | |
| SCHEMBL1033190 | 0.84 | NAAA (0.45) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL16401942 | 0.84 | NAAA (0.45) | MEN1KMT2AALDH1A1LMNATSHR | |
| SCHEMBL13412090 | 0.81 | KDM4E (0.41) | NLRP3SMN1; SMN2MEN1KMT2AALDH1A1 | |
| SCHEMBL1035454 | 0.80 | KDM4E (0.34) | NLRP3SMN1; SMN2MEN1KMT2AMAPK1 | |
| SCHEMBL1034997 | 0.79 | KDM4E (0.40) | SMN1; SMN2MEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL25250098 | 0.78 | ATM (0.40) | NLRP3SMN1; SMN2MEN1KMT2AMAPK1 | |
| SCHEMBL1034147 | 0.74 | NLRP3 (0.48) | NLRP3CYP3A4SMN1; SMN2MEN1KMT2A | |
| SCHEMBL1037277 | 0.73 | LMNA (0.37) | SMN1; SMN2MEN1KMT2AMAPK1ALDH1A1 | |
| SCHEMBL1035839 | 0.73 | TSHR (0.48) | SMN1; SMN2MEN1KMT2AALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160137756-A1 | Water Based Concentrated Product Forms of Photoinitiators Made by a Heterophase Polymerization Technique | BASF SE (DE) | 2016-05-19 | — | — | US | disclosed |
| US-20160137756-A1 | Water Based Concentrated Product Forms of Photoinitiators Made by a Heterophase Polymerization Technique | BASF SE (DE) | 2016-05-19 | — | — | US | disclosed |
| US-20160137756-A1 | Water Based Concentrated Product Forms of Photoinitiators Made by a Heterophase Polymerization Technique | BASF SE (DE) | 2016-05-19 | — | — | US | disclosed |
| EP-2035496-B1 | WATER BASED CONCENTRATED PRODUCT FORMS OF PHOTOINITIATORS MADE BY A HETEROPHASE POLYMERIZATION TECHNIQUE | BASF SE (DE) | 2014-07-30 | — | — | EP | disclosed |
| EP-2035496-B1 | WATER BASED CONCENTRATED PRODUCT FORMS OF PHOTOINITIATORS MADE BY A HETEROPHASE POLYMERIZATION TECHNIQUE | BASF SE (DE) | 2014-07-30 | — | — | EP | disclosed |
| EP-1814891-B1 | BISACYLPHOSPHANES AND THEIR USE AS PHOTOINITIATORS; PROCESS FOR PREPARING ACYLPHOSPHANES | BASF SE (DE) | 2011-01-26 | — | — | EP | disclosed |
| EP-1814891-B1 | BISACYLPHOSPHANES AND THEIR USE AS PHOTOINITIATORS; PROCESS FOR PREPARING ACYLPHOSPHANES | BASF SE (DE) | 2011-01-26 | — | — | EP | disclosed |
| US-20100234484-A1 | Water based concentrated product forms of photoinitiators made by a heterophase polymerization technique | IGM GROUP B.V. (NL) | 2010-09-16 | — | — | US | disclosed |
| US-20100234484-A1 | Water based concentrated product forms of photoinitiators made by a heterophase polymerization technique | IGM GROUP B.V. (NL) | 2010-09-16 | — | — | US | disclosed |
| US-20100234484-A1 | Water based concentrated product forms of photoinitiators made by a heterophase polymerization technique | IGM GROUP B.V. (NL) | 2010-09-16 | — | — | US | disclosed |
| US-7687657-B2 | Process for preparing acylphosphanes and derivatives thereof | CIBA SPECIALITY CHEMICALS CORPORATION (US) | 2010-03-30 | — | — | US | disclosed |
| US-7687657-B2 | Process for preparing acylphosphanes and derivatives thereof | CIBA SPECIALITY CHEMICALS CORPORATION (US) | 2010-03-30 | — | — | US | disclosed |
| EP-2035496-A1 | WATER BASED CONCENTRATED PRODUCT FORMS OF PHOTOINITIATORS MADE BY A HETEROPHASE POLYMERIZATION TECHNIQUE | Ciba Holding Inc. (CH) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008003601-A1 | WATER BASED CONCENTRATED PRODUCT FORMS OF PHOTOINITIATORS MADE BY A HETEROPHASE POLYMERIZATION TECHNIQUE | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| WO-2008003601-A1 | WATER BASED CONCENTRATED PRODUCT FORMS OF PHOTOINITIATORS MADE BY A HETEROPHASE POLYMERIZATION TECHNIQUE | CIBA HOLDING INC. (CH) | 2008-01-10 | — | — | WO | disclosed |
| US-20080004464-A1 | Process for Preparing Acylphosphanes and Derivatives Thereof | IGM GROUP B.V. (NL) | 2008-01-03 | — | — | US | disclosed |
| US-20080004464-A1 | Process for Preparing Acylphosphanes and Derivatives Thereof | IGM GROUP B.V. (NL) | 2008-01-03 | — | — | US | disclosed |
| US-20080004464-A1 | Process for Preparing Acylphosphanes and Derivatives Thereof | IGM GROUP B.V. (NL) | 2008-01-03 | — | — | US | disclosed |
| EP-1814891-A1 | PROCESS FOR PREPARING ACYLPHOSPHANES AND DERIVATIVES THEREOF | Ciba Specialty Chemicals Holding Inc. (CH) | 2007-08-08 | — | — | EP | disclosed |
| WO-2006056541-A1 | PROCESS FOR PREPARING ACYLPHOSPHANES AND DERIVATIVES THEREOF | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080004464-A1 | Process for Preparing Acylphosphanes and Derivatives Thereof | ME2, ME3, MEP1A | NLRP3 4879/4885CYP3A4 552/4885SMN1; SMN2 3557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.